Literature DB >> 7857985

PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow.

Y Denizot1, F Trimoreau, F Dupuis, C Verger, V Praloran.   

Abstract

Platelet-activating factor (PAF) is a phospholipid compound with major immunoregulatory activities. The present study shows that human bone marrow contains 576 +/- 39 pg PAF/ml (n = 35). Bone marrow-derived PAF exhibits the same biophysical and biological properties that synthetic PAF. PAF concentrations in bone marrow are correlated with the granulocyte (r = 0.4, P = 0.02) but not with the lymphocyte (r = 0.24, P = 0.17) and the monocyte (r = 0.12, P = 0.48) counts. In bone marrow PAF is inactivated by a plasma PAF acetylhydrolase activity (48.0 +/- 2.3 nmol/min per ml, n = 34). Experiments with [3H]PAF indicate that human bone marrow cells actively metabolize this potent molecule by the deacetylation-transacylation pathway. Results of this investigation indicate the permanent presence of significant amounts of PAF in bone marrow suggesting its putative involvement in the processes of bone marrow cell proliferation and maturation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857985     DOI: 10.1016/0167-4889(94)00193-i

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors.

Authors:  F Dupuis; N Gachard; A Allegraud; C Dulery; V Praloran; Y Denizot
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

2.  Eicosanoid and cytokine levels in plasma of patients during mesenteric infarction.

Authors:  N Nathan; Y Denizot; P Feiss
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.